J. Biol. Chem., Vol. 263, Issue 35, 18640-18649, 12, 1988

The catalytic site of rat hepatic lauric acid omega-hydroxylase. Protein versus prosthetic heme alkylation in the omega-hydroxylation of acetylenic fatty acids

CA CaJacob, WK Chan, E Shephard and PR Ortiz de Montellano
Department of Pharmaceutical Chemistry, School of Pharmacy, University of California, San Francisco 94143.

Cytochrome P-450LA omega purified from clofibrate-induced rat liver oxidizes lauric acid to 11- and 12-hydroxydodecanoic acid in approximately a 1:17 ratio at a rate of 20 nmol/nmol P-450/min. In contrast, cytochrome P-450b oxidizes lauric acid much more slowly (0.5 nmol/nmol P-450/min) to an 8:1 mixture of the same metabolites. Western blot analysis indicates that P-450LA omega accounts for 1-2 and 16-30%, respectively, of the total cytochrome P-450 in uninduced and clofibrate- induced rat liver. Cytochrome b5 increases the efficiency of omega- hydroxylation but not the rate of catalytic turnover. Incubation of the enzyme with 10-undecynoic acid (10-UDYA) results in loss of approximately 45% of the enzymatic activity but none of the enzyme chromophore. Approximately 1 mol of 1,11-undecandioic acid is produced per mole of inactivated enzyme. This extraordinary inactivation efficiency is confirmed by NADPH consumption studies. Approximately 0.5 equivalents of label are covalently bound to the enzyme when it is incubated with 14C-labeled 10-UDYA. 11-Dodecenoic acid appears not to be a substrate for cytochrome P-450LA omega but is oxidized, presumably by a contaminating isozyme, to a 10:1 mixture of 11,12-epoxydodecanoic acid and 12-oxododecanoic acid. The results suggest the presence of two closely related P-450LA omega enzymes, only one of which is susceptible to inactivation by 10-UDYA. They also indicate that cytochrome P-450LA omega has a highly structured active site that sterically suppresses omega-1-hydroxylation in order to deliver the oxygen to the thermodynamically disfavored terminal carbon. Protein rather than heme alkylation follows from this reaction regiospecificity.
CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				H.-l. Lin and P. F. Hollenberg The Inactivation of Cytochrome P450 3A5 by 17{alpha}-Ethynylestradiol Is Cytochrome b5-Dependent: Metabolic Activation of the Ethynyl Moiety Leads to the Formation of Glutathione Conjugates, a Heme Adduct, and Covalent Binding to the Apoprotein J. Pharmacol. Exp. Ther., April 1, 2007; 321(1): 276 - 287. [Abstract] [Full Text] [PDF]

				S. Kandel, M. Morant, I. Benveniste, E. Blee, D. Werck-Reichhart, and F. Pinot Cloning, Functional Expression, and Characterization of CYP709C1, the First Sub-terminal Hydroxylase of Long Chain Fatty Acid in Plants: INDUCTION BY CHEMICALS AND METHYL JASMONATE J. Biol. Chem., October 28, 2005; 280(43): 35881 - 35889. [Abstract] [Full Text] [PDF]

				X. He, M. J. Cryle, J. J. O. De Voss, and P. R. de Montellano Calibration of the Channel That Determines the {omega}-Hydroxylation Regiospecificity of Cytochrome P4504A1: CATALYTIC OXIDATION OF 12-HALODODECANOIC ACIDS J. Biol. Chem., June 17, 2005; 280(24): 22697 - 22705. [Abstract] [Full Text] [PDF]

				P. W. Fan, C. Gu, S. A. Marsh, and J. C. Stevens Mechanism-Based Inactivation of Cytochrome P450 2B6 by a Novel Terminal Acetylene Inhibitor Drug Metab. Dispos., January 1, 2003; 31(1): 28 - 36. [Abstract] [Full Text] [PDF]

				F. Xu, W. O. Straub, W. Pak, P. Su, K. G. Maier, M. Yu, R. J. Roman, P. R. Ortiz De Montellano, and D. L. Kroetz Antihypertensive effect of mechanism-based inhibition of renal arachidonic acid omega -hydroxylase activity Am J Physiol Regulatory Integrative Comp Physiol, September 1, 2002; 283(3): R710 - R720. [Abstract] [Full Text] [PDF]

				A. P. Armstrong and P. F. Hollenberg Mechanism-Based Inactivation of Rat Liver Cytochrome 2B1 by 2-Methoxy-5-nitrobenzyl Bromide Drug Metab. Dispos., June 1, 1999; 27(6): 741 - 745. [Abstract] [Full Text]

				E. A. Dierks, Z. Zhang, E. F. Johnson, and P. R. O. de Montellano The Catalytic Site of Cytochrome P4504A11 (CYP4A11) and Its L131F Mutant J. Biol. Chem., September 4, 1998; 273(36): 23055 - 23061. [Abstract] [Full Text] [PDF]

				P. Su, K. M. Kaushal, and D. L. Kroetz Inhibition of renal arachidonic acid omega -hydroxylase activity with ABT reduces blood pressure in the SHR Am J Physiol Regulatory Integrative Comp Physiol, August 1, 1998; 275(2): R426 - R438. [Abstract] [Full Text] [PDF]

				C. Helvig, C. Alayrac, C. Mioskowski, D. Koop, D. Poullain, F. Durst, and J.-P. Salaun Suicide Inactivation of Cytochrome P450 by Midchain and Terminal Acetylenes. A MECHANISTIC STUDY OF INACTIVATION OF A PLANT LAURIC ACID omega -HYDROXLYASE J. Biol. Chem., January 3, 1997; 272(1): 414 - 421. [Abstract] [Full Text] [PDF]

				P. J. Loida, S. G. Sligar, M. D. Paulsen, G. E. Arnold, and R. L. Ornstein Stereoselective Hydroxylation of Norcamphor by Cytochrome P450[IMAGE] J. Biol. Chem., March 10, 1995; 270(10): 5326 - 5330. [Abstract] [Full Text] [PDF]

				U. Hoch and P. R. Ortiz de Montellano Covalently Linked Heme in Cytochrome P4504A Fatty Acid Hydroxylases J. Biol. Chem., March 30, 2001; 276(14): 11339 - 11346. [Abstract] [Full Text] [PDF]